Share Name Share Symbol Market Type Share ISIN Share Description
Fitbug LSE:FITB London Ordinary Share GB00B57JBH88 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.215p 0.21p 0.22p 0.215p 0.215p 0.215p 372,706.00 07:30:13
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Leisure Goods 1.3 -6.5 -2.5 - 2.65

Fitbug (FITB) Latest News

More Fitbug News
Fitbug Takeover Rumours

Fitbug (FITB) Share Charts

1 Year Fitbug Chart

1 Year Fitbug Chart

1 Month Fitbug Chart

1 Month Fitbug Chart

Intraday Fitbug Chart

Intraday Fitbug Chart

Fitbug (FITB) Discussions and Chat

Fitbug (FITB) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
08:22:090.21100,000212.00O
08:00:470.21272,706572.68O
07:15:310.221,000,0002,150.00O
06/12/2016 12:52:110.212,080,8554,369.80O
06/12/2016 09:41:180.2144,01992.44O
View all Fitbug trades in real-time

Fitbug (FITB) Top Chat Posts

DateSubject
06/12/2016
08:20
Fitbug Daily Update: Fitbug is listed in the Leisure Goods sector of the London Stock Exchange with ticker FITB. The last closing price for Fitbug was 0.22p.
Fitbug has a 4 week average price of 0.22p and a 12 week average price of 0.23p.
The 1 year high share price is 1.78p while the 1 year low share price is currently 0p.
There are currently 1,231,366,968 shares in issue and the average daily traded volume is 1,948,582 shares. The market capitalisation of Fitbug is £2,647,438.98.
27/11/2016
09:26
knigel: Do you work for Fitbug? So much promotion - so little movement in share price or RNSs from the company - BBs do not move share prices - news from the company will..
07/11/2016
08:08
dusseldorf: rameshh - My view on Fitbug has not changed (though I used to be interested in buying, but remained cautious, research first unlike most it seems) and by not buying into the hype - I saved lots of money. You can trade as opposed to invest, but 90% of those who do, lose, because they are greedy or believe every company will fulfill its vision and put in more eliminating prior profit. Avoiding poor stocks is an equal to investing in good ones - I have learned this through experience - yes, I've made poor investments before - but you have to learn from it. mudbath - fair enough re: your trade. historic 'watchlist' traders (waiting for something for old times sake) and the lemming brigade can spike any share price. Something needs to happen here, so on the basis that NW1 want to make some money back at some point - there may well be action in the coming months. The price is fair for a speculative punt (as opposed to backing legacy business) IMO, so if that's your game - good luck, you could well trade out a profit.
23/12/2015
16:32
liquid millionaire: FITB obviously have some serious supporters who truly believe in what they are doing. Todays RNS is better much better than endless dilutive share placings. I for one like it and can see why the FITB share price has responded the way that it has i.e. positive +
21/6/2015
15:31
knigel: A BOD has no direct control over the share price. Did they take "credit" for the share price going from 0.6p to 26p in a matter of weeks? NO The reason why it went up so fast was because of some decent news flow and greedy private investors piling in alongside the usual rampers pushing it up (who move from share to share to day trade)... why did it go back down? Obviously because the same private investors (inc me) took massive profits and as the share price continued to fall - more banked profits causing a further slide. I agree that the BOD did not help matters with the 9p share placing but it's the best way for any company to raise funds for investment/expansion and hopefully we will see the fruits in the second half of 2015. BTW 90% of Ackers posts are links and excellent research - only a few of his posts have included his share price prediction(s).. and we all probably have a share price target for when to buy/sell with any investment... no one makes anyone buy or sell any share - we must take responsibility.. and stop blaming or pointing the finger at others..
20/6/2015
11:04
joosepi: D Mail Business 19th June 2015: INVESTORS’ hearts were a-flutter on the Street of Dreams as shares in Fitbit opened 51pc above the float price of $20, valuing the company well north of $4bn or £2.6bn. Wearable fitness technology has become huge business in the US and Fitbit has a 68pc market share. President Barack Obama was recently photographed wearing a Fitbit Surge wristband which tracks fitness levels such as calories burnt, which obviously gave the company a pre-float boost. Tomas Freyman, valuations partner at BDO UK, said: ‘Fitbit’s valuation of $4bn is indicative of just how huge the wearable healthtech market has become. The growth of the firm has been astronomical, particularly the net income in the first-quarter of 2015, around $40m more than the same time in 2014.’ Fitbit possibly only first came to the attention of the London market in March 2013 when AIM-listed and London-based Fitbug, 0.05p dearer at 4.62p and valued at only £10.8m, filed a lawsuit against Fitbit alleging trademark infringement and unfair business practices, which Fitbug claimed caused it irreparable harm and damage. Fitbit denied the allegations and successfully defended the claim before the District Court based on a laches defence. Worries about what in effect was a David versus Goliath battle didn’t do the Fitbug share price any favours. It slumped from a November 2014 peak of 26.5p,a level which had been boosted by news that its products would be stocked by three retail giants – Amazon, Sainsbury’s, and Target in the US. Buyers were back nibbling away yesterday after hearing that in-flight retail specialist Scorpio Worldwide will include a Fitbug Kiqplan product bundle in its range of products provided to major airlines. Its first confirmed airline customer is Dutch airline KLM, part of Air France-KLM, which will stock a Fitbug Orb wearable device and Kiqplan product on board flights from October 2015.
10/12/2014
13:40
liquid millionaire: FITB Repeat FITB Just out ref: FITB Subject: Fitbug Holdings PLC: £3.5m placing to fund sales drive Hybridan Research The provider of online personal health and wellbeing services yesterday announced a placing of £3.5m at a price of 9p. Fitbug has announced a string of high profile partnerships and retail agreements of late with the likes of Target and Samsung UK which sent the share price up to as high as 26.375p on an intraday basis. The funds will be predominantly applied to the marketing of the Fitbug Orb and the recently launched online coaching platform, Kiqplan, which is compatible with the majority of wearable devices. This combination, in our opinion, gives Fitbug a unique position to capitalise upon the fast growing demand for wearable technology, and incorporation of fitness tracking sensors into smartphones. We understand that the marketing strategy will be primarily focused on the US and UK. Fitbug will be attending the Consumer Electronics Show in January. Kiqplan has relevance to anybody wishing to achieve lifestyle improvement goals, and as such sponsorship of high profile public sporting events (fun runs etc) will provide a viable platform to reach new audiences. We also understand that Fitbug is pursuing a number of further retail partnerships and is seeking to appoint a global head of marketing. The admission of the placing shares on 30 December will be accompanied by the issue of 33.3m shares in respect of the conversion of 50% of a £1m loan note from Kifin Limited, a Kirsh Group subsidiary. Under the terms of the note issued in 2012 the conversion price is 1.5p. The company has for some time relied on the support of the Kirsh Group and NW1 Investments (a related party). The continuing support was demonstrated as recently as the 26 November announcement of the extension of all other loans to July 2016 (£6.9m). Within that figure is included loan proceeds of £2.35m issued in H2 2014. These funds combined with the placing proceeds, give Fitbug the resources to maximise its first mover advantage, and the opportunity to reach profitability with no further support from external backers. There are currently 13 million options of which 3 million are being surrendered and an additional 13.1 million are being granted including 8.5million to directors at the placing price under the enterprise management incentive scheme. David Turner, who currently holds 3m options intends to surrender these immediately after Admission following his move to a non-executive role earlier in 2014. CEO Malcolm Fried, having completed his task of refreshing Fitbug’s strategic direction, will be stepping down at the year end and Chairman, Fergus Kee, will revert to his executive role. Paul Landau, the founder of the Fitbug business, remains CEO of Fitbug Limited, the main operating company The combination of rapidly expanding retail base, and the high margin scalable cross-platform Kiqplans, give us confidence that H2 2014 and beyond will demonstrate rapid revenue growth. Should Target alone gross $100 per store per week in sales of Fitbug products that would add circa £3m in annual revenues. At this stage of Fitbug’s aggressive growth drive, revenue visibility is limited and we look forward to further details of due course. As we detailed in our note of 24 October, the wearable space has been the subject of much corporate activity with several transactions going through in excess of $100m. We believe that Fitbug’s capability of reaching multiple devices is unique in that it enables the company to target a higher proportion of the customers expected to buy over 43m of wearable bands worldwide next year. The recent launch of the Samsung Gear S and ever evolving pipeline of new devices, such as the Apple iWatch due for release in spring 2015 will keep the sector in focus for some time to come. The litigation against the market leader in basic bands, Fitbit, for trademark infringement is due to reach the courts in February 2015. We understand from the company that there is likely to be little downside and potentially significant upside for Fitbug from this case, and that under the US legal system costs cannot be awarded against a litigant who fails to prove their case. Fitbit on the other hand would appear to have much at risk including the potential loss of the Fitbit mark.
10/12/2014
11:55
liquid millionaire: Just out ref: FITB Subject: Fitbug Holdings PLC: £3.5m placing to fund sales drive Hybridan Research The provider of online personal health and wellbeing services yesterday announced a placing of £3.5m at a price of 9p. Fitbug has announced a string of high profile partnerships and retail agreements of late with the likes of Target and Samsung UK which sent the share price up to as high as 26.375p on an intraday basis. The funds will be predominantly applied to the marketing of the Fitbug Orb and the recently launched online coaching platform, Kiqplan, which is compatible with the majority of wearable devices. This combination, in our opinion, gives Fitbug a unique position to capitalise upon the fast growing demand for wearable technology, and incorporation of fitness tracking sensors into smartphones. We understand that the marketing strategy will be primarily focused on the US and UK. Fitbug will be attending the Consumer Electronics Show in January. Kiqplan has relevance to anybody wishing to achieve lifestyle improvement goals, and as such sponsorship of high profile public sporting events (fun runs etc) will provide a viable platform to reach new audiences. We also understand that Fitbug is pursuing a number of further retail partnerships and is seeking to appoint a global head of marketing. The admission of the placing shares on 30 December will be accompanied by the issue of 33.3m shares in respect of the conversion of 50% of a £1m loan note from Kifin Limited, a Kirsh Group subsidiary. Under the terms of the note issued in 2012 the conversion price is 1.5p. The company has for some time relied on the support of the Kirsh Group and NW1 Investments (a related party). The continuing support was demonstrated as recently as the 26 November announcement of the extension of all other loans to July 2016 (£6.9m). Within that figure is included loan proceeds of £2.35m issued in H2 2014. These funds combined with the placing proceeds, give Fitbug the resources to maximise its first mover advantage, and the opportunity to reach profitability with no further support from external backers. There are currently 13 million options of which 3 million are being surrendered and an additional 13.1 million are being granted including 8.5million to directors at the placing price under the enterprise management incentive scheme. David Turner, who currently holds 3m options intends to surrender these immediately after Admission following his move to a non-executive role earlier in 2014. CEO Malcolm Fried, having completed his task of refreshing Fitbug’s strategic direction, will be stepping down at the year end and Chairman, Fergus Kee, will revert to his executive role. Paul Landau, the founder of the Fitbug business, remains CEO of Fitbug Limited, the main operating company The combination of rapidly expanding retail base, and the high margin scalable cross-platform Kiqplans, give us confidence that H2 2014 and beyond will demonstrate rapid revenue growth. Should Target alone gross $100 per store per week in sales of Fitbug products that would add circa £3m in annual revenues. At this stage of Fitbug’s aggressive growth drive, revenue visibility is limited and we look forward to further details of due course. As we detailed in our note of 24 October, the wearable space has been the subject of much corporate activity with several transactions going through in excess of $100m. We believe that Fitbug’s capability of reaching multiple devices is unique in that it enables the company to target a higher proportion of the customers expected to buy over 43m of wearable bands worldwide next year. The recent launch of the Samsung Gear S and ever evolving pipeline of new devices, such as the Apple iWatch due for release in spring 2015 will keep the sector in focus for some time to come. The litigation against the market leader in basic bands, Fitbit, for trademark infringement is due to reach the courts in February 2015. We understand from the company that there is likely to be little downside and potentially significant upside for Fitbug from this case, and that under the US legal system costs cannot be awarded against a litigant who fails to prove their case. Fitbit on the other hand would appear to have much at risk including the potential loss of the Fitbit mark.
27/11/2014
09:15
waspfactory: Act your age not the FITB share price
25/11/2014
17:30
leebong: It’s been a fantastic few weeks for investors in Fitbug (LSE: FITB), with shares in the seller of fitness devices rising by a whopping 320% in the last week, and an incredible 5272% in the last month. The key reason for their very recent gains has been a deal struck with Samsung, with the electronics giant agreeing to include the company’s KiQplan digital coaching product on its Digital Health platform. The agreement could help to improve consumer awareness of Fitbug and, with the company offering additional features that are exclusively available to Samsung customers (such as a 12-week plan called ‘Fit+Healthy’), the move could help to build brand loyalty among Samsung customers. In addition, shares in Fitbug have also benefited in recent weeks from the stocking of the company’s products in Sainsbury’s, as well as in Target stores in the US. With such major retailers getting on board, the market clearly believes that Fitbug could have a bright future, and more major retailers could follow their peers and begin to stock the company’s products. Future Potential Clearly, wearable technology devices such as those sold by Fitbug have huge growth potential. Furthermore, when they are combined with a focus on health and wellbeing, it could prove to be a potent mix and, in this respect, Fitbug seems to have superb potential. In addition, a glance at Fitbug’s offering confirms that it could develop a niche product. That’s because it offers the same features as more expensive options, such as those sold by Nike, for a fraction of the cost. So, Fitbug could carve out its own segment in a fast-growing industry and make health-focused wearable technology devices much more accessible for consumers. This could be hugely beneficial to investors through a higher share price. Looking Ahead Of course, Fitbug remains a company that has no revenue and is therefore impossible to value. Furthermore, the chances of the company’s share price continuing its rise at the same pace are slim. After all, it has struck multiple deals with major corporations and, while others may follow, they are unlikely to cause such a dramatic rise in the company’s share price in the short run. That’s because further success appears to now be priced in, with the market seemingly anticipating sales figures to impress over the near term. Although wearable technology focused on health and wellbeing is undoubtedly an industry with vast potential, whether Fitbug can tap into that growth is yet to be tested. As a result, Fitbug remains a very high-risk play, with its share price set to remain volatile until data regarding its sales comes through. As such, prudent investors may wish to wait for evidence of its success – especially after a period of such strong share price growth – before buying a slice of the company. After all, patience has never lost anyone any money. Clearly, investing in Fitbug has been a highly profitable move for most investors in the stock
28/10/2014
11:55
mudbath: Retail contracts for the Orb have no bearing on the FITB share price rise imo. We are seeing the EARLY STAGES of recognition that Nathan Kirsh via Kilfin might inject his US $ 6 BILLION private company assets into what,on conversion of outstanding loans (some at 1.5pence)would be a shell controlled by Kirsh and existing directors.They are currently mopping up the free float. Just surprised that it took so long for people to spot the glaring potential for the share price to rise not to 10 pence but to many multiples of that figure. (posted last year. On the face of it Fitbug is the next AIM candidate for administration,boasting a negative shareholder equity of £1.88 million against a current market cap of £1.4million,a loss for the past 6 months of £1.05 million on declining revenues of just £461k. It has been able to continue trading purely on the back of loans provided by the Kirch Group and associated companies. These loans total a staggering(relatively speaking)£3.75 million. £2.75million of the loans are repayable in 6 months time with the remaining £1million in 18 months. Subject to certain criteria,the loans are convertible. Whilst a significant uplift in revenues is forecast,it seems impossible that FITB will be able repay all or part of these loans,meaning that the Kirsh Group and those other private companies working in tandem, could end up, following conversion of loans into shares,of some 80% of the enlarged equity. Nathan Kirsh, who has a net worth of at least $5.1 billion, according to the Bloomberg Billionaires Index is 81 years old and is making plans to hand over the reins of control. “We are private, we are profitable and we have fun,” the billionaire, who has never appeared on an international wealth ranking, said in an interview at his office in North London in October. “We just don’t scream about what we do.” In October, Kirsh acquired a white-stucco fronted Georgian building next to London’s Madame Tussauds waxworks tourist attraction near Regents Park. The building will become the new headquarters for the Kirsh Group in June, bringing his disparate portfolio of assets and businesses under one roof for the first time. The operation, he said, will one day be managed by Ron Sandler, the former CEO of the Lloyd’s of London insurance market who was also appointed by the U.K. government as chairman of Northern Rock Plc, which was nationalized in 2008. Kirsh states, “All of my businesses are profitable. I am in the best space I have ever been.” My reason for investing and believing that FITB could at least double is based solely on the involvement of the Kirsh family,the singular mismatching of their status and level of support in relation to Fitbug's size and ability to repay,paving the way for FITB to become a majority owned company and a possible vehicle for the injection of Kirsh Group assets. At worst Fitbug could end up fully funded at the commencement of on upward trend in its fortunes. Finally, the expansion of Fitbit,a similarly named US$300million capitalized US competitor has resulted in a quantum leap in traffic to the FITB web site. Fitbug are currently involved in legal action against Fitbit in the US claiming breach of copyright. Pure speculation of course. Nevertheless FITB should be an interesting company to follow this year. Priced just above its all time low as well @ 0.875 pence.)
Fitbug share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20161207 08:38:12